CAR T-cell therapy is a form of cellular immunotherapy that is changing how blood cancers like lymphoma, leukemia and multiple myeloma are treated. Dr. Melhem Solh, a hematologist with the Northside Hospital Cancer Institute Blood Cancer Program, explains how this treatment works by reprogramming a patient’s own T cells to recognize and destroy cancer cells more effectively.
While CAR T-cell therapy offers hope for many, it is just one part of a personalized cancer treatment plan. Every patient’s journey is different, and it is important to discuss all available options with your care team.
Watch as Dr. Solh explains the CAR T cell process and how this innovative therapy is helping patients fight cancer.
